Compugen (CGEN) Income from Continuing Operations (2009 - 2026)

Compugen's (CGEN) quarterly Income from Continuing Operations came in at 7659000.0 in Q1 2026, up 7.59% year-on-year from 7119000.0 in Q1 2025, and down 86.5% quarter-over-quarter from 56737000.0 in Q4 2025.

Compugen (CGEN) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Compugen has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 7659000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 7659000.0, up 7.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 35883000.0 (up 772.34% YoY), and the FY2025 annual result was 35343000.0, up 348.35% from the prior year.
  • Income from Continuing Operations came in at 7659000.0 for Q1 2026 at Compugen, down from 56737000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 56737000.0 in Q4 2025 to a low of 28000000.0 in Q2 2023.
  • The 5-year median for Income from Continuing Operations is 3092000.0 (2022), against an average of 1352647.06.
  • Across the five-year window, Income from Continuing Operations tumbled 198.03% in 2023 and jumped 1027.53% in 2025, its largest moves.
  • Compugen's Income from Continuing Operations stood at 3092000.0 in 2022, then surged by 414.13% to 9713000.0 in 2023, then plunged by 162.98% to 6117000.0 in 2024, then surged by 1027.53% to 56737000.0 in 2025, then tumbled by 86.5% to 7659000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 7659000.0 (Q1 2026), 56737000.0 (Q4 2025), and 6899000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 7.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.66 Mn
Dec 31, 2025 56.74 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 -21.61 Mn
Mar 31, 2025 7.12 Mn
Dec 31, 2024 -6.12 Mn
Sep 30, 2024 10.28 Mn
Jun 30, 2024 -16.62 Mn
Mar 31, 2024 7.26 Mn
Dec 31, 2023 9.71 Mn
Sep 30, 2023 -9.85 Mn
Jun 30, 2023 -28.00 Mn
Mar 31, 2023 9.31 Mn
Dec 31, 2022 -3.09 Mn
Sep 30, 2022 -11.75 Mn
Jun 30, 2022 28.56 Mn
Mar 31, 2022 -9.71 Mn
Dec 31, 2021 -8.65 Mn
Sep 30, 2021 -8.18 Mn
Jun 30, 2021 -9.50 Mn